Access
To read this story in full you will need to login or make a payment (see right).
Insight
Nature 454, 436-444 (24 July 2008) | doi:10.1038/nature07205; Published online 23 July 2008
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Executive- Commercial- Corporate Office
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
Professor
- University of Cincinnati and Cincinnati Children's Research Foundation
- Cincinnati, OH
Review Article Cancer-related inflammation
Alberto Mantovani1,2, Paola Allavena1, Antonio Sica3 & Frances Balkwill4
Abstract
The mediators and cellular effectors of inflammation are important constituents of the local environment of tumours. In some types of cancer, inflammatory conditions are present before a malignant change occurs. Conversely, in other types of cancer, an oncogenic change induces an inflammatory microenvironment that promotes the development of tumours. Regardless of its origin, 'smouldering' inflammation in the tumour microenvironment has many tumour-promoting effects. It aids in the proliferation and survival of malignant cells, promotes angiogenesis and metastasis, subverts adaptive immune responses, and alters responses to hormones and chemotherapeutic agents. The molecular pathways of this cancer-related inflammation are now being unravelled, resulting in the identification of new target molecules that could lead to improved diagnosis and treatment.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Cancer An infernal triangleNature News and Views (02 Aug 2007)
Cancer Inflaming metastasisNature News and Views (01 Jan 2009)
Chemokines: Not just leukocyte chemoattractants in the promotion of cancerNature Immunology News and Views (01 Apr 2001)
